VEGFA and neoplasm: Bevacizumab is a recombinant humanized monoclonal antibody, containing the structural region of a human antibody, which can selectively bind to VEGF and block its biological activity, thus blocking VEGF-mediated tumor angiogenesis and delaying tumor growth [8].